Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of N-Acetylcysteine for Treatment of Overt Diabetic Nephropathy

NCT00556465 is registered in ClinicalTrials.gov with Shiraz University of Medical Sciences as lead sponsor.

NCT NCT00556465
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00556465 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of N-Acetylcysteine for Treatment of Overt Diabetic Nephropathy
Lead sponsor
Shiraz University of Medical Sciences
Phase
Phase 2/3
Overall status
Completed
Start date
January 31, 2007
Completion date
June 30, 2007
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic kidney disease, diabetes type 2, diabetic nephropathy